One more Partner for the Team at Foresite Capital

Foresite Capital is a health care and growth equity firm that has chosen to announce the entry of another partner, Molly He. Molly is a former senior director at Illumina and she brings with her more than a decade and a half experience in the Pharmaceutical industry with a special focus on genomic research and development.

According to Jim Tananbaum, Dr. He is one of the most respectable and reputable science researchers in the next generation sequencing field. Because of this, Jim, who is the CEO and MD of Foresite Capital is thrilled and excited to welcome her on board. It is believed that her remarkable leadership record of accomplishment and excellent result delivery in the genomic and drug development industry will be an invaluable resource to the company. She will serve as the much-needed resources for the expansion and diversification of the company’s portfolio, which is necessary for its growth and transformation.Sourced Info: Drewaltizer.com

As one of the senior directors at Illumina, Dr. He was the company’s global protein reagent innovation and improvements. Before then she was the head of protein sciences at the Pacific Biosciences where her responsibility was developing protein reagents for the company’s single molecule real time chemistry sequencing. She had spent ten years early in her career in the pharmaceutical industry focusing on structural based designed antibodies as well as small-molecule drugs that targeted immune diseases as well as cancer. Click here: https://ideamensch.com/jim-tananbaum/

Dr. He is a Biochemistry degree holder from Nankai University and also has a PhD in Biophysics from the university of California, Los Angeles. She has authored more than 20 published papers and is a patent holder of more than 20 patent applications. She has been issued patents in the field of next generation sequencing as well as personalized medicine.

About Jim Tannanbaum

Jim Tannanbaum was named the CEO and managing director of Foresite capital early this year. Jim has been named in three consecutive years as the best tech investor in the Forbes Midas list.

Dr. Jim is a leader in this industry with two and a half decades of offering innovative solutions for the health care. He graduated from Yale with BS/BSEE degrees and an MBA and MD from Harvard. He also has an M.S from MIT. He has everything it takes to excel in this industry. More details can be found on LinkedIn.com.

See more: http://pelotontherapeutics.com/bod-jim-tananbaum/

Leave a Reply

Your email address will not be published. Required fields are marked *